Skip to main content

Parexel to be acquired in $8.5B private-equity deal

Parexel, the clinical research giant co-headquartered in Newton, Mass., and Durham, N.C., is being snapped up in a private-equity deal worth $8.5 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.